Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting-Reference-Cited by-同舟云学术

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting

Published:2017-02 Issue:1 Volume:27 Page:66-74
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Childress Ann C.¹,Kollins Scott H.²,Cutler Andrew J.³,Marraffino Andrea⁴,Sikes Carolyn R.⁵

Affiliation:

1. Center for Psychiatry and Behavioral Medicine, Las Vegas, Nevada.

2. Department of Psychiatry and Behavioral Science, Duke University, Durham, North Carolina.

3. Florida Clinical Research Center, Bradenton, Florida.

4. Florida Clinical Research Center, Orlando, Florida.

5. Neos Therapeutics, Inc., Grand Prairie, Texas.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2016.0002

Reference36 articles.

1. Advances in understanding and treating ADHD

2. Attention-deficit hyperactivity disorder

3. An Update on Central Nervous System Stimulant Formulations in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Novel FDA-Approved Psychiatric Medications (2018-2022);Cureus;2024-03-20

2. Therapeutic Use of Dopamine Enhancers (Stimulants);Tasman’s Psychiatry;2024

3. Prevalence of Headache Due to the Use of Methylphenidate: A Systematic Review;European Journal of Medical and Health Research;2023-11-01

4. An updated safety review of the current drugs for managing ADHD in children;Expert Opinion on Drug Safety;2023-10-24

5. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD);Cochrane Database of Systematic Reviews;2023-03-27